Having trouble viewing this email? View in your browser.

07 Mai 2019

Dear colleagues,

Please find below the latest edition of ESCMID Weekly News.

With kind regards,

ESCMID Executive Office.


ESCMID Membership Counsellor: A new key figure in the ESCMID Community.

ESCMID aims to continuously increase the transparency in its procedures and involvement of members, external partners and employees. For this reason, ESCMID has established the position of ESCMID Membership Counsellor (EMeC), a contact person for all ESCMID affiliates. The Counsellor, a two-year appointed ad hoc Executive Committee Member, represents an additional conduit by which the ESCMID community may discuss ideas, problems and issues within the Society.

Prof. Murat Akova has been instilled as the inaugural ESCMID Membership Counsellor.

For more information about the ESCMID Membership Counsellor, please click here.

› Read more

5th ESCMID Conference on Vaccines – Call for Abstracts and Grants

Submissions are now open for Abstracts and Attendance Grants for the 5th ESCMID Conference on Vaccines, to be held in Bilbao, Spain, from 6-8 September 2019. This edition of the conference will focus on vaccines against respiratory infections and the development of new vaccines.

Find out more, apply and register on the course website.

› Read more

HIV Cure Symposium and Reservoir Characterisation Workshop 2019

ESCMID is proud to endorse the HIV Cure Symposium and Reservoir Characterisation Workshop that will be held in the beautiful city of Ghent, Belgium, September 16-20, 2019.  

In the fifth edition of this workshop, different techniques and assays that are developed and optimized to chacterize the HIV reservoir are discussed and teached, with a focus on practical work.  

Click here to register

› Read more

Survey on Point of Care testing (POCT) for seasonal influenza and other respiratory viruses

The Executive Committee of ESCMID Study Group for Respiratory Viruses would like to invite ESCMID members to respond to the "Survey on Point of Care testing (POCT) for seasonal influenza and other respiratory viruses". This survey aims to capture the current status of use of point of care testing in the ESCMID community and to highlight areas of best practice and areas where further work is required. Please fill in the survey by following this link:


Please feel free to share this survey with your colleagues; that would substantially help collect solid data from Europe and beyond.

› Read more

ESCMID Guidelines Subcommittee to present the new ESCMID model for guidelines at the EBMLive congress 2019.

The EBMLive congress (Oxford, UK, 15-17 July 2019), co-organized by the Centre for Evidence-Based Medicine of Oxford University and the British Medical Journal aims at making evidence relevant and replicable for policy, patients and professionals in healthcare.

ESCMID will present its programme for guideline development to meet the huge challenges in how guidance documents are perceived (trustworthy guidelines) and developed (useful guidelines), and discuss lessons learnt and plans for the future, responding to the challenges posed by a recent thought-provoking editorial.

› Read more

The impact of carbapenemase producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study

M. Giannella et al. investigate the impact of colonization with carbapenemase producing Enterobacteriaceae (CPE) on the CPE infection risk after liver transplantation (LT).

Prospective cohort study of all adult patients undergoing LT at our center over 8-year period (2010-2017). Patients were screened for CPE colonization by rectal swabs at inclusion on waiting list, immediately before LT, and weekly after LT until hospital discharge. Asymptomatic carriers did not receive decolonization, anti-CPE prophylaxis or preemptive antibiotic therapy. Patients were followed-up to 1 year after LT.

The authors determined that CPE colonization at LT or colonization acquired after LT were the strongest predictors of CPE infection. Therefore, prevention strategies focused on LT candidates and recipients colonized with CPE should be investigated.

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Phone +41 61 5080 173
Visit us on LinkedIn Visit us on YouTube
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.